Published in Proc Natl Acad Sci U S A on July 03, 2001
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature (2009) 6.99
Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J (2002) 2.26
Molecular features of the copper binding sites in the octarepeat domain of the prion protein. Biochemistry (2002) 2.16
Molecular neurology of prion disease. J Neurol Neurosurg Psychiatry (2005) 2.15
The cellular prion protein (PrP(C)): its physiological function and role in disease. Biochim Biophys Acta (2007) 2.09
Interaction between prion protein and toxic amyloid β assemblies can be therapeutically targeted at multiple sites. Nat Commun (2011) 1.96
The octarepeat domain of the prion protein binds Cu(II) with three distinct coordination modes at pH 7.4. J Am Chem Soc (2005) 1.80
Copper coordination in the full-length, recombinant prion protein. Biochemistry (2003) 1.66
Copper and the prion protein: methods, structures, function, and disease. Annu Rev Phys Chem (2007) 1.56
Aβ neurotoxicity depends on interactions between copper ions, prion protein, and N-methyl-D-aspartate receptors. Proc Natl Acad Sci U S A (2012) 1.38
Copper binding in the prion protein. Acc Chem Res (2004) 1.29
Cell-surface prion protein interacts with glycosaminoglycans. Biochem J (2002) 1.27
The affinity of copper binding to the prion protein octarepeat domain: evidence for negative cooperativity. Biochemistry (2006) 1.20
Copper-dependent regulation of NMDA receptors by cellular prion protein: implications for neurodegenerative disorders. J Physiol (2012) 1.19
The role of the cellular prion protein in the immune system. Clin Exp Immunol (2006) 1.09
High content screening in zebrafish speeds up hazard ranking of transition metal oxide nanoparticles. ACS Nano (2011) 1.08
Zinc drives a tertiary fold in the prion protein with familial disease mutation sites at the interface. Structure (2013) 1.08
The effects of prion protein proteolysis and disaggregation on the strain properties of hamster scrapie. J Gen Virol (2008) 1.05
Conformation of prion protein repeat peptides probed by FRET measurements and molecular dynamics simulations. Biophys J (2004) 0.99
Human serum albumin coordinates Cu(II) at its N-terminal binding site with 1 pM affinity. J Biol Inorg Chem (2007) 0.98
Multiple forms of copper (II) co-ordination occur throughout the disordered N-terminal region of the prion protein at pH 7.4. Biochem J (2006) 0.98
pH-dependent association of factor VIII chains: enhancement of affinity at physiological pH by Cu2+. Biochim Biophys Acta (2006) 0.94
Redox control of prion and disease pathogenesis. Antioxid Redox Signal (2010) 0.93
Detection of bovine spongiform encephalopathy, ovine scrapie prion-related protein (PrPSc) and normal PrPc by monoclonal antibodies raised to copper-refolded prion protein. Biochem J (2003) 0.93
Probing the role of PrP repeats in conformational conversion and amyloid assembly of chimeric yeast prions. J Biol Chem (2007) 0.92
A reassessment of copper(II) binding in the full-length prion protein. Biochem J (2006) 0.92
Copper alters aggregation behavior of prion protein and induces novel interactions between its N- and C-terminal regions. J Biol Chem (2011) 0.91
Identification of the minimal copper(II)-binding alpha-synuclein sequence. Inorg Chem (2009) 0.90
Checking the pH-induced conformational transition of prion protein by molecular dynamics simulations: effect of protonation of histidine residues. Biophys J (2004) 0.90
Dominant-negative effects of the N-terminal half of prion protein on neurotoxicity of prion protein-like protein/doppel in mice. J Biol Chem (2008) 0.90
Copper induces increased beta-sheet content in the scrapie-susceptible ovine prion protein PrPVRQ compared with the resistant allelic variant PrPARR. Biochem J (2004) 0.89
The Soluble Form of the Cellular Prion Protein Enhances Phagocytic Activity and Cytokine Production by Human Monocytes Via Activation of ERK and NF-κB. Immune Netw (2013) 0.89
Stability and Cu(II) binding of prion protein variants related to inherited human prion diseases. Biophys J (2003) 0.88
Recombinant prion protein does not possess SOD-1 activity. Biochem J (2005) 0.87
Conformational properties of beta-PrP. J Biol Chem (2009) 0.87
Functional implications of multistage copper binding to the prion protein. Proc Natl Acad Sci U S A (2009) 0.86
Infectious prion protein alters manganese transport and neurotoxicity in a cell culture model of prion disease. Neurotoxicology (2011) 0.86
Identification of the copper(II) coordinating residues in the prion protein by metal-catalyzed oxidation mass spectrometry: evidence for multiple isomers at low copper(II) loadings. Biochemistry (2008) 0.86
Fragmentation and dimerization of copper-loaded prion protein by copper-catalysed oxidation. Biochem J (2005) 0.85
Glycosylation-related genes are variably expressed depending on the differentiation state of a bioaminergic neuronal cell line: implication for the cellular prion protein. Glycoconj J (2008) 0.85
Prion protein (PrP) gene-knockout cell lines: insight into functions of the PrP. Front Cell Dev Biol (2015) 0.85
Prion sequence polymorphisms and chronic wasting disease resistance in Illinois white-tailed deer (Odocoileus virginianus). Prion (2008) 0.84
Ab initio simulations of Cu binding sites on the N-terminal region of prion protein. J Biol Inorg Chem (2007) 0.84
Metal binding kinetics of bi-histidine sites used in psi analysis: evidence of high-energy protein folding intermediates. Biochemistry (2009) 0.83
Modeling the interplay of glycine protonation and multiple histidine binding of copper in the prion protein octarepeat subdomains. J Biol Inorg Chem (2008) 0.83
The prion protein family: a view from the placenta. Front Cell Dev Biol (2014) 0.83
Prion protein and aging. Front Cell Dev Biol (2014) 0.83
Binding of alpha-synuclein with Fe(III) and with Fe(II) and biological implications of the resultant complexes. J Inorg Biochem (2009) 0.83
Synergistic effects of metal ion and the pre-senile cataract-causing G98R alphaA-crystallin: self-aggregation propensities and chaperone activity. Mol Vis (2009) 0.82
Neuronal zinc regulation and the prion protein. Prion (2013) 0.82
A spectroscopic and voltammetric study of the pH-dependent Cu(II) coordination to the peptide GGGTH: relevance to the fifth Cu(II) site in the prion protein. J Biol Inorg Chem (2006) 0.82
Ligand binding promotes prion protein aggregation--role of the octapeptide repeats. FEBS J (2008) 0.82
Green fluorescent protein as a reporter of prion protein folding. Virol J (2006) 0.82
Identification and characterization of a copper-binding site in αA-crystallin. Free Radic Biol Med (2011) 0.82
Anion effects on sodium ion and acid molecule adduction to protein ions in electrospray ionization mass spectrometry. J Am Soc Mass Spectrom (2011) 0.82
ESEEM analysis of multi-histidine Cu(II)-coordination in model complexes, peptides, and amyloid-β. J Phys Chem B (2014) 0.82
A Structural and Functional Comparison Between Infectious and Non-Infectious Autocatalytic Recombinant PrP Conformers. PLoS Pathog (2015) 0.81
Fragment length influences affinity for Cu2+ and Ni2+ binding to His96 or His111 of the prion protein and spectroscopic evidence for a multiple histidine binding only at low pH. Biochem J (2007) 0.81
Gerstmann-Straüssler-Scheinker disease: novel PRNP mutation and VGKC-complex antibodies. Neurology (2014) 0.80
Studies of the transmissibility of the agent of bovine spongiform encephalopathy to the domestic chicken. BMC Res Notes (2011) 0.80
Glutamate receptors function as scaffolds for the regulation of β-amyloid and cellular prion protein signaling complexes. Mol Brain (2015) 0.80
De novo mammalian prion synthesis. Prion (2009) 0.79
A new method to determine the structure of the metal environment in metalloproteins: investigation of the prion protein octapeptide repeat Cu(2+) complex. Eur Biophys J (2004) 0.79
Effect of divalent metals on the neuronal proteasomal system, prion protein ubiquitination and aggregation. Toxicol Lett (2012) 0.79
Interactions of prion protein with intracellular proteins: so many partners and no consequences? Cell Mol Neurobiol (2009) 0.79
Both Met(109) and Met(112) are utilized for Cu(II) coordination by the amyloidogenic fragment of the human prion protein at physiological pH. J Inorg Biochem (2008) 0.78
Octarepeat region flexibility impacts prion function, endoproteolysis and disease manifestation. EMBO Mol Med (2015) 0.78
Insights into prion protein function from atomistic simulations. Prion (2010) 0.78
Copper-induced structural propensities of the amyloidogenic region of human prion protein. J Biol Inorg Chem (2014) 0.77
Real-time kinetics of discontinuous and highly conformational metal-ion binding sites of prion protein. J Biol Inorg Chem (2007) 0.77
Cellular prion protein: A co-receptor mediating neuronal cofilin-actin rod formation induced by β-amyloid and proinflammatory cytokines. Prion (2014) 0.77
In Absence of the Cellular Prion Protein, Alterations in Copper Metabolism and Copper-Dependent Oxidase Activity Affect Iron Distribution. Front Neurosci (2016) 0.76
Prion fragment peptides are digested with membrane type matrix metalloproteinases and acquire enzyme resistance through Cu²⁺-binding. Biomolecules (2014) 0.76
Calorimetric investigation of copper binding in the N-terminal region of the prion protein at low copper loading: evidence for an entropically favorable first binding event. Inorg Chem (2014) 0.76
Evolutionary implications of metal binding features in different species' prion protein: an inorganic point of view. Biomolecules (2014) 0.76
Polymorphisms at amino acid residues 141 and 154 influence conformational variation in ovine PrP. Biomed Res Int (2014) 0.75
New insights into structural determinants of prion protein folding and stability. Prion (2015) 0.75
The Cellular Prion Protein Prevents Copper-Induced Inhibition of P2X(4) Receptors. Int J Alzheimers Dis (2011) 0.75
Prion protein scrapie and the normal cellular prion protein. Prion (2016) 0.75
Copper(II) complexes with chicken prion repeats: influence of proline and tyrosine residues on the coordination features. J Biol Inorg Chem (2005) 0.75
Copper-induced structural conversion templates prion protein oligomerization and neurotoxicity. Sci Adv (2016) 0.75
Metal Dyshomeostasis and Their Pathological Role in Prion and Prion-Like Diseases: The Basis for a Nutritional Approach. Front Neurosci (2017) 0.75
Antioxidant and Metal Chelation-Based Therapies in the Treatment of Prion Disease. Antioxidants (Basel) (2014) 0.75
Prions. Proc Natl Acad Sci U S A (1998) 27.80
Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins. Proc Natl Acad Sci U S A (1993) 10.36
Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase. Science (1999) 6.86
The cellular prion protein binds copper in vivo. Nature (1998) 3.92
Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry (1993) 3.54
Strain-specific prion-protein conformation determined by metal ions. Nat Cell Biol (1999) 2.61
Copper stimulates endocytosis of the prion protein. J Biol Chem (1998) 2.47
Copper binding to the prion protein: structural implications of four identical cooperative binding sites. Proc Natl Acad Sci U S A (1999) 2.44
Prion protein selectively binds copper(II) ions. Biochemistry (1998) 2.32
An efficient 3D NMR technique for correlating the proton and 15N backbone amide resonances with the alpha-carbon of the preceding residue in uniformly 15N/13C enriched proteins. J Biomol NMR (1991) 2.17
Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science (1999) 1.95
Normal prion protein has an activity like that of superoxide dismutase. Biochem J (1999) 1.87
Copper binding to the N-terminal tandem repeat region of mammalian and avian prion protein: structural studies using synthetic peptides. Biochem Biophys Res Commun (1995) 1.76
Copper binding to the N-terminal tandem repeat regions of mammalian and avian prion protein. Biochem Biophys Res Commun (1995) 1.72
Copper binding to octarepeat peptides of the prion protein monitored by mass spectrometry. Protein Sci (2000) 1.57
Structural mobility of the human prion protein probed by backbone hydrogen exchange. Nat Struct Biol (1999) 1.41
Brain copper content and cuproenzyme activity do not vary with prion protein expression level. J Biol Chem (2000) 1.37
Mammalian prion proteins. Curr Opin Struct Biol (2000) 1.24
Structure of an engineered, metal-actuated switch in trypsin. Biochemistry (1993) 0.99
Histopathological similarities between scrapie and cuprizone toxicity in mice. Nature (1971) 0.88
The same prion strain causes vCJD and BSE. Nature (1997) 12.49
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Mutations in T-cell antigen receptor genes alpha and beta block thymocyte development at different stages. Nature (1992) 7.66
Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet (2001) 5.57
Homozygous prion protein genotype predisposes to sporadic Creutzfeldt-Jakob disease. Nature (1991) 5.04
Diagnosis of new variant Creutzfeldt-Jakob disease by tonsil biopsy. Lancet (1997) 4.28
T cell receptor delta gene mutant mice: independent generation of alpha beta T cells and programmed rearrangements of gamma delta TCR genes. Cell (1993) 4.18
Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet (1999) 4.02
129/Ola mice carrying a null mutation in PrP that abolishes mRNA production are developmentally normal. Mol Neurobiol (1995) 3.60
Germ line transmission and expression of a corrected HPRT gene produced by gene targeting in embryonic stem cells. Cell (1989) 3.20
Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. Genes Dev (1999) 2.91
Transmission of Creutzfeldt-Jakob disease from humans to transgenic mice expressing chimeric human-mouse prion protein. Proc Natl Acad Sci U S A (1994) 2.70
Prion protein is necessary for normal synaptic function. Nature (1994) 2.69
Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature (1992) 2.66
A specific, highly active malate dehydrogenase by redesign of a lactate dehydrogenase framework. Science (1988) 2.63
Strain-specific prion-protein conformation determined by metal ions. Nat Cell Biol (1999) 2.61
High-frequency developmental abnormalities in p53-deficient mice. Curr Biol (1995) 2.57
Species-barrier-independent prion replication in apparently resistant species. Proc Natl Acad Sci U S A (2000) 2.50
Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J (2002) 2.26
EcoRV restriction endonuclease binds all DNA sequences with equal affinity. Biochemistry (1991) 2.23
PrP gene dosage determines the timing but not the final intensity or distribution of lesions in scrapie pathology. Neurodegeneration (1994) 2.21
Location of a folding protein and shape changes in GroEL-GroES complexes imaged by cryo-electron microscopy. Nature (1994) 2.19
Post-exposure prophylaxis after accidental prion inoculation. Lancet (1997) 2.15
Insertion in prion protein gene in familial Creutzfeldt-Jakob disease. Lancet (1989) 2.11
Calcium-induced structural changes and domain autonomy in calmodulin. Nat Struct Biol (1995) 2.09
Rapid cell-surface prion protein conversion revealed using a novel cell system. Nat Commun (2011) 2.04
Design and synthesis of new enzymes based on the lactate dehydrogenase framework. Philos Trans R Soc Lond B Biol Sci (1991) 2.02
ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B). Neurology (2006) 2.00
Identification of multiple quantitative trait loci linked to prion disease incubation period in mice. Proc Natl Acad Sci U S A (2001) 1.96
Reversible conversion of monomeric human prion protein between native and fibrilogenic conformations. Science (1999) 1.95
Age-dependent synuclein pathology following traumatic brain injury in mice. Exp Neurol (2003) 1.89
The meiotic checkpoint monitoring synapsis eliminates spermatocytes via p53-independent apoptosis. Nat Genet (1998) 1.87
Inherited prion disease with 144 base pair gene insertion. 1. Genealogical and molecular studies. Brain (1992) 1.86
Tissue handling in suspected Creutzfeldt-Jakob disease (CJD) and other human spongiform encephalopathies (prion diseases) Brain Pathol (1995) 1.86
A single amino acid substitution in lactate dehydrogenase improves the catalytic efficiency with an alternative coenzyme. Biochem Biophys Res Commun (1990) 1.84
Folding of peptide fragments comprising the complete sequence of proteins. Models for initiation of protein folding. I. Myohemerythrin. J Mol Biol (1992) 1.79
Binding and hydrolysis of nucleotides in the chaperonin catalytic cycle: implications for the mechanism of assisted protein folding. Biochemistry (1993) 1.78
Sporadic Creutzfeldt-Jakob disease in a 16-year-old in the UK. Lancet (1995) 1.78
Sporadic Creutzfeldt-Jakob disease in a 18-year-old in the UK. Lancet (1995) 1.76
Cloning, expression and complete nucleotide sequence of the Bacillus stearothermophilus L-lactate dehydrogenase gene. Gene (1986) 1.76
Structure of TCTP reveals unexpected relationship with guanine nucleotide-free chaperones. Nat Struct Biol (2001) 1.75
Molecular screening of sheep for bovine spongiform encephalopathy. Neurosci Lett (1998) 1.74
Irregular presence of abnormal prion protein in appendix in variant Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry (2002) 1.72
Early onset familial Alzheimer's disease: Mutation frequency in 31 families. Neurology (2003) 1.71
Transmission of scrapie by steel-surface-bound prions. Mol Med (2001) 1.63
Identification of amino acid residues critical for aggregation of human CC chemokines macrophage inflammatory protein (MIP)-1alpha, MIP-1beta, and RANTES. Characterization of active disaggregated chemokine variants. J Biol Chem (1999) 1.62
Novel mechanism of hydrolysis of therapeutic beta-lactams by Stenotrophomonas maltophilia L1 metallo-beta-lactamase. J Biol Chem (2001) 1.61
Codon 129 changes in the prion protein gene in Caucasians. Am J Hum Genet (1990) 1.52
Transmission of Creutzfeldt-Jakob disease by handling of dura mater. Lancet (1993) 1.52
Sporadic--but not variant--Creutzfeldt-Jakob disease is associated with polymorphisms upstream of PRNP exon 1. Am J Hum Genet (2001) 1.50
An integrated kinetic analysis of intermediates and transition states in protein folding reactions. J Mol Biol (1995) 1.49
High-resolution structure of a potent, cyclic proteinase inhibitor from sunflower seeds. J Mol Biol (1999) 1.48
Lymphocyte contamination of laryngoscope blades--a possible vector for transmission of variant Creutzfeldt-Jakob disease. Anaesthesia (2005) 1.45
Site-directed mutagenesis reveals role of mobile arginine residue in lactate dehydrogenase catalysis. Nature (1987) 1.43
The origins and consequences of asymmetry in the chaperonin reaction cycle. J Mol Biol (1995) 1.42
Three-dimensional domain swapping in the folded and molten-globule states of cystatins, an amyloid-forming structural superfamily. EMBO J (2001) 1.42
Structural mobility of the human prion protein probed by backbone hydrogen exchange. Nat Struct Biol (1999) 1.41
Blue light curing units--a dermatological hazard? Br Dent J (1994) 1.40
The adenovirus and the egg: a new approach to transgenesis. Nat Biotechnol (1996) 1.39
Natural protoplast Dunaliella as a source of protein. Appl Environ Microbiol (1976) 1.39
Multiparameter MR imaging in the 6-OPRI variant of inherited prion disease. AJNR Am J Neuroradiol (2013) 1.39
Creation of a large genomic deletion at the T-cell antigen receptor beta-subunit locus in mouse embryonic stem cells by gene targeting. Proc Natl Acad Sci U S A (1991) 1.39
Binding of a chaperonin to the folding intermediates of lactate dehydrogenase. Biochemistry (1991) 1.38
High frequency of persistent hyperplastic primary vitreous and cataracts in p53-deficient mice. Cell Death Differ (1998) 1.38
Transmission of fatal familial insomnia to laboratory animals. Lancet (1995) 1.37
Prion protein gene analysis in new variant cases of Creutzfeldt-Jakob disease. Lancet (1996) 1.37
Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP gene. Hum Genet (1996) 1.36
Chaperonins can catalyse the reversal of early aggregation steps when a protein misfolds. J Mol Biol (1995) 1.36
Nurse endoscopists in United Kingdom health care: a survey of prevalence, skills and attitudes. J Adv Nurs (2001) 1.35
The role of Stat3 in apoptosis and mammary gland involution. Conditional deletion of Stat3. Adv Exp Med Biol (2000) 1.34
Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine. Proc Natl Acad Sci U S A (1999) 1.33
The human papillomavirus (HPV) 16 E2 protein induces apoptosis in the absence of other HPV proteins and via a p53-dependent pathway. J Biol Chem (2000) 1.33
Efficient BLG-Cre mediated gene deletion in the mammary gland. Transgenic Res (1998) 1.33
Mating compatibility among four pest members of the Bactrocera dorsalis fruit fly species complex (Diptera: Tephritidae). J Econ Entomol (2013) 1.32
Determinants of DNA-binding specificity of ETS-domain transcription factors. Mol Cell Biol (1996) 1.32
Phenotypic heterogeneity and genetic modification of P102L inherited prion disease in an international series. Brain (2008) 1.30
Hippocampal slices from prion protein null mice: disrupted Ca(2+)-activated K+ currents. Neurosci Lett (1996) 1.29
Multiple folding pathways for heterologously expressed human prion protein. Biochim Biophys Acta (1999) 1.29
Crystal structure of human prion protein bound to a therapeutic antibody. Proc Natl Acad Sci U S A (2009) 1.29
CpG methylation directly inhibits binding of the human papillomavirus type 16 E2 protein to specific DNA sequences. J Virol (1996) 1.26
HTLV-I--associated B-cell CLL: indirect role for retrovirus in leukemogenesis. Science (1987) 1.25
Characterization of the Elk-1 ETS DNA-binding domain. J Biol Chem (1995) 1.24
Fatal familial insomnia: a new Austrian family. Brain (1999) 1.24
Mammalian prion proteins. Curr Opin Struct Biol (2000) 1.24
Dysregulated expression of beta-catenin marks early neoplastic change in Apc mutant mice, but not all lesions arising in Msh2 deficient mice. Oncogene (1999) 1.24
Protease-resistant prion protein produced in vitro lacks detectable infectivity. J Gen Virol (1999) 1.24
Binding, encapsulation and ejection: substrate dynamics during a chaperonin-assisted folding reaction. J Mol Biol (1997) 1.23
P53-dependent and -independent links between DNA-damage, apoptosis and mutation frequency in ES cells. Oncogene (1999) 1.23
Amide backbone and water-related H/D isotope effects on the dynamics of a protein folding reaction. Biochemistry (1997) 1.21